Equity Overview
Price & Market Data
Price: $1.43
Daily Change: -$0.03 / 2.10%
Range: $1.43 - $1.48
Market Cap: $41,293,392
Volume: 2,519
Performance Metrics
1 Week: 18.67%
1 Month: 9.54%
3 Months: 23.52%
6 Months: -32.96%
1 Year: 18.18%
YTD: 17.21%
Company Details
Employees: 9
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.